Invivogen
Menu

Original strain - His-tagged RBD Protein

Product Unit size Cat. code Docs. Price

Spike-RBD-His

SARS-CoV-2 Spike RBD-His fusion protein

Show product

50 µg

his-sars2-rbd

SARS-CoV-2 Spike RBD with C-terminal His tag

Protein description

Potential applications of soluble spike proteins
Potential applications of soluble spike proteins

The SARS-CoV-2 (2019-nCoV) Spike RBD (receptor binding domain) has been identified as the key viral element allowing the virus docking to the target cells. RDB is recognized by the ACE2 surface membrane receptor [1-3]. RBD is a candidate for subunit prophylactic vaccines against SARS-CoVs [4, 5]. RBD is also at the center of therapeutic approaches, such as the development and testing of small peptide inhibitors or soluble ACE2 to block the SARS-CoV-2 entry into target cells [6].
Spike-RBD-His was generated by fusing the C-terminus of SARS-CoV-2 Spike RBD [R319-F541] to a poly-histidine sequence (6 x His).
The SARS-CoV-2 viral sequence used is from the Wuhan-Hu-1 (D614) isolate.
This protein has been produced in CHO cells and purified by affinity chromatography (See Details and Specifications for more information).

Applications

  • Vaccination studies: using combinations of Spike protein antigens and adjuvants
  • Antibody screening: finding anti-Spike antibodies that can neutralize the SARS-CoV-2 infection
  • Inhibitor screening: finding small molecules, or antibodies able to block the SARS-CoV-2 RBD interaction with the ACE2 receptor
  • ACE2 cellular expression screening: in primary isolated cells or transfected cells

Quality control

 

Learn more on SARS-CoV-2Learn more about SARS-CoV-2 infection cycle, immune responses, and potential therapeutics.

 

References

1. Li F., 2016. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3:237-261.
2. Li F. et al., 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 309:1864-1868.
3. Walls A.C. et al., 2020. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 181(2):281-292.e6.
4. Wang N. et al., 2020. Subunit vaccines against emerging pathogenic human coronaviruses. Front. Microbiol. 11:298. DOI: 10.3389/fmicb.2020.00298.
5. Padron-Regalado E., 2020. Vaccines for SARS-CoV-2: Lessons from other coronavirus strains. Infect. Dis. Ther. DOI: 10.1007/s40121-020-00300-x.
6. Monteil V.et al., 2020. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 181:1-9.

Figures

Spike-RBD-His analysis by SDS PAGE
Spike-RBD-His analysis by SDS PAGE

SDS PAGE analysis of the Spike-RBD-His protein. 2 μg of the fusion protein  was loaded on a 12% Mini-PROTEAN® TGX Stain-Free™ Precast Gels (Bio-Rad). Detection was performed as per manufacturer’s intructions.

Recognition of Spike-RBD-His by anAnti-SARS-CoV-Spike human IgM
Recognition of Spike-RBD-His by anAnti-SARS-CoV-Spike human IgM

ELISA detection of the SARS-CoV-2 Spike-RBD-His fusion protein with the Anti-SARS-CoV-Spike human IgM. Anti-SARS-CoV-Spike hIgM antibody (5 μg/ml) was coated on ELISA plates overnight. A 3-fold serial dilution of Spike-RBD-His (red curve) or of ACP5-His control protein  (grey  curve) was realized for the capture step. An HRP-labelled anti-His antibody (1/1000 dilution) and the HRP substrate OPD (o-phenylenediamine dihydrochloride) were used for the detection step. Absorbance was read at 490 nm.

Back to the top

Specifications

 

  • Protein construction: RBD [R319-F541] from the Spike glycoprotein with a C-terminal poly-histidine tag 
  • Accession sequence: YP_009724390
  • Species: SARS-CoV-2 (2019-nCoV); Wuhan-Hu-1 (D614) isolate
  • Tag: C-terminal poly-histidine (6 x His)
  • Total protein size: 234 a.a. (secreted form)
  • Molecular weight: ~30 kDa (SDS-PAGE gel)
  • Purification: Ni2+ affinity chromatography
  • Purity: >95% (SDS-PAGE)
  • Quality control:
    - The protein has been validated by ELISA upon incubation with a coated Anti-SARS-CoV-Spike-RBD hIgM mAb (clone CR3022)
    - The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cellular assays.
Back to the top

Contents

 

  • 50 μg of lyophilized protein
  • 1.5 ml of endotoxin-free water

room temperature The product is shipped at room temperature.

store Lyophilized protein should be stored at -20°C.

stability Resuspended protein is stable for up to 1 month when stored at 4°C, and 1 year when stored at -20°C

Avoid repeated freeze-thaw cycles.

Back to the top

Details

Learn more about the SARS-CoV-2 Spike protein.

Back to the top
Customer Service
& Technical Support
Shopping cart is empty